Amgen

BLINCYTO

  1. Home
  2.  / 
  3. J Code
  4.  / BLINCYTO – J9039

Manufacturer:

Amgen

Name:

BLINCYTO

HCPCS Code Descriptor:

Injection, blinatumomab, 1 microgram

Category:

J Code

HCPCS:

J9039

NDC(s):

55513-0160-01

Primary Type:

Oncology

Generic/Specialty Status:

Single-Source

Route of Administration:

Intravenous

Potential NDC Listing Errors:

Our team did not identify any potential listing errors/discrepancies for the NDCs mapped to this HCPCS code.

About:

BLINCYTO is an Oncology drug manufactured by Amgen and administered via the Intravenous route of administration. The J Code: J9039 is aligned to the drug BLINCYTO.

Access Pricing and More By Registering

HCPCS Added Date:

1/1/16

HCPCS Effective Date:

1/1/16

HCPCS Short Description:

Injection, blinatumomab

Billing and Coding Guide:

https://www.blincytohcp.com/mrd/-/media/Themes/Amgen/BlincytoHCP/BlincytoHCP/PDFs/Blincyto_Billing_Coding_Guide.pdf

Patient Assistance:

https://www.amgenassist.com/copay

http://www.amgensafetynetfoundation.com

BLINCYTO - J9039